Perrigo Acquires JB Laboratories

Perrigo Acquires JB Laboratories

Perrigo Acquires JB Laboratories

 

 

In a move that is expected to boost annual sales by more than $70 million, Perrigo Company, Allegan, MI, has acquired JB Laboratories, Holland, MI, for approximately $44 million in cash.

Privately-held JB Laboratories is a contract manufacturer of over-the-counter (OTC) and nutrition products for leading healthcare suppliers in the U.S.

"The acquisition of JB Laboratories will further expand our high-quality manufacturing base and provide additional FDA-approved production capacity to help us service our current and future customer needs,” said Joseph Papa, Perrigo's chairman and CEO. “And in addition to the immediate top line sales contribution, this investment will be accretive to earnings this year and beyond. This acquisition further exemplifies Perrigo's commitment to meeting the world's growing need for quality, affordable healthcare."

Perrigo Company is a leading global healthcare supplier that develops, manufactures and distributes OTC and prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients and consumer products. The company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market, with primary markets and manufacturing facilities in the U.S., Israel, Mexico and the U.K.

Boutique executive search services with best in class global network, contacts and market mastery.

Deeply connected and engaged personal service approach, long-term investment in client community and 25 year history of strong relations with both Multi-National leaders and Private Equity partners.